Hauschulz, M.; Villwock, S.; Kosinski, J.; Steib, F.; Heij, L.R.; Bednarsch, J.; Knüchel-Clarke, R.; Dahl, E.
Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Cancers 2023, 15, 683.
https://doi.org/10.3390/cancers15030683
AMA Style
Hauschulz M, Villwock S, Kosinski J, Steib F, Heij LR, Bednarsch J, Knüchel-Clarke R, Dahl E.
Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Cancers. 2023; 15(3):683.
https://doi.org/10.3390/cancers15030683
Chicago/Turabian Style
Hauschulz, Maximilian, Sophia Villwock, Jennifer Kosinski, Florian Steib, Lara Rosaline Heij, Jan Bednarsch, Ruth Knüchel-Clarke, and Edgar Dahl.
2023. "Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer" Cancers 15, no. 3: 683.
https://doi.org/10.3390/cancers15030683
APA Style
Hauschulz, M., Villwock, S., Kosinski, J., Steib, F., Heij, L. R., Bednarsch, J., Knüchel-Clarke, R., & Dahl, E.
(2023). Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Cancers, 15(3), 683.
https://doi.org/10.3390/cancers15030683